Dr. Alan Rudolph

Vice President for Research, Colorado State University
Chief of Biological Sciences and Technology, US Defense Advanced Research Projects Agency (DARPA)

Dr. Alan Rudolph has had an active career in translating interdisciplinary life sciences into useful applications for biotechnology development and commercialization. His experience spans basic research to advanced development in academia, government laboratories, and in the nonprofit and private sectors. His scientific training translated into positions of leadership in each of these sectors with management of over $4B in investments in life sciences and biotechnology. Working for the Defense Department at the US Navy and the Defense Advanced Research Projects Agency, he led major programs in biological defense and biotechnology. 

As founder and CEO, Dr. Rudolph led companies in medical countermeasures including stabilized cell therapeutics at Cellphire and protein diagnostics at Adlyfe. He served as Vice President of Research at Colorado State University for a decade where he led a major expansion of research revenues and impacts launching new institutes in One Health, Healthy Aging, Soil Carbon Solutions and Data Sciences. Dr. Rudolph currently is an advisor for Cedar Street Group and Innosphere Ventures which invest in proof of concept stage companies in order to scale to impact and a board member of early stage companies. He has published more than 100 technical publications, three books, and has a number of issued patents from his work. 

Dr. Rudolph has a doctorate degree in Zoology from the University of California at Davis and an MBA from George Washington University.